Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2015 07/22/2015 07/23/2015 07/24/2015 07/27/2015 Date
204.88(c) 206.16(c) 207.84(c) 200.99(c) 198.1(c) Last
916 669 1 041 302 1 012 050 1 827 229 1 671 529 Volume
+0.21% +0.62% +0.81% -3.30% -1.44% Change
More quotes
Financials ($)
Sales 2015 2 633 M
EBIT 2015 1 153 M
Net income 2015 565 M
Debt 2015 150 M
Yield 2015 -
Sales 2016 3 417 M
EBIT 2016 1 617 M
Net income 2016 905 M
Finance 2016 609 M
Yield 2016 -
PER 2015 73,70
PER 2016 45,53
EV / Sales 2015 17,0x
EV / Sales 2016 12,9x
Capitalization 44 732 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
07/30Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
07/17 ALEXION PHARMACEUTICALS : Strensiq (asfotase alfa) Gets Marketing Approval in Ja..
07/13 ALEXION PHARMACEUTICALS : to Report Second Quarter 2015 Results on Thursday, Jul..
07/10 ALEXION PHARMACEUTICALS : Strensiq (asfotase alfa) Secures Marketing Approval in..
07/09 ALEXION PHARMACEUTICALS : Strensiq (asfotase alfa) Gets Marketing OK in Japan fo..
07/09 ALEXION PHARMACEUTICALS' : Strensiq Garners Receives Marketing Approval in Japan..
07/06 ALEXION PHARMACEUTICALS : Strensiq® (asfotase alfa) Receives Marketing Approval ..
07/06 ALEXION PHARMACEUTICALS : Gets CHMP Positive Opinions for Strensiq (asfotase alf..
07/06 ALEXION PHARMACEUTICALS : Updates on CHMP Positive Opinions for Strensiq (asfota..
More news
Sector news : Biopharmaceuticals
06:15a Hikma to buy Boehringer's U.S. generic drug business for $2.65 billion
05:16aDJLONDON MARKETS : FTSE 100 On Track To Break Losing Streak As RSA Rallies; Pound ..
05:02a ORION : Group Interim Report January-June 2015
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/09 BIOTECH AT A FRAUGHT MID-YEAR : An Overview And Look Ahead
07/06 Alexion's Strensiq cleared in Japan for rare metabolic disorder
07/03 No Letting Up In Pharma As First-Half Gains Outweigh Losses
06/26 Europe's CHMP adopts positive opinion supporting approval for two Alexion enz..
06/22 INSIDERINSIGHTS.COM DAILY ROUND UP 6 : Banc, ntip, lub, alxn


Comments 
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions